School of Medicine, Deakin University, Geelong, VIC, Australia.
Department of Medical Laboratory Technology, Southern Technical University, Basra, Iraq.
Front Cell Infect Microbiol. 2022 Oct 28;12:887278. doi: 10.3389/fcimb.2022.887278. eCollection 2022.
BCL6A is a transcriptional repressor implicated in the development and survival of B and T lymphoctyes, which is also highly expressed in many non-Hodgkin's lymphomas, such as diffuse large B cell lymphoma and follicular lymphoma. Roles in other cell types, including macrophages and non-hematopoietic cells, have also been suggested but require further investigation. This study sought to identify and characterize zebrafish BCL6A and investigate its role in immune cell development and function, with a focus on early macrophages. Bioinformatics analysis identified a homologue for BCL6A (), as well as an additional fish-specific duplicate () and a homologue for the closely-related BCL6B (). The human BCL6A and zebrafish Bcl6aa proteins were highly conserved across the constituent BTB/POZ, PEST and zinc finger domains. Expression of during early zebrafish embryogenesis was observed in the lateral plate mesoderm, a site of early myeloid cell development, with later expression seen in the brain, eye and thymus. Homozygous mutants developed normally until around 14 days post fertilization (dpf), after which their subsequent growth and maturation was severely impacted along with their relative survival, with heterozygous mutants showing an intermediate phenotype. Analysis of immune cell development revealed significantly decreased lymphoid and macrophage cells in both homozygous and heterozygous mutants, being exacerbated in homozygous mutants. In contrast, the number of neutrophils was unaffected. Only the homozygous mutants showed decreased macrophage mobility in response to wounding and reduced ability to contain bacterial infection. Collectively, this suggests strong conservation of BCL6A across evolution, including a role in macrophage biology.
BCL6A 是一种转录抑制剂,涉及 B 和 T 淋巴细胞的发育和存活,在许多非霍奇金淋巴瘤中高度表达,如弥漫性大 B 细胞淋巴瘤和滤泡性淋巴瘤。在其他细胞类型中的作用,包括巨噬细胞和非造血细胞,也有被提出,但需要进一步研究。本研究旨在鉴定和描述斑马鱼 BCL6A,并研究其在免疫细胞发育和功能中的作用,重点是早期巨噬细胞。生物信息学分析鉴定了 BCL6A 的同源物(),以及另外一个鱼类特异性重复()和密切相关的 BCL6B 的同源物()。人类 BCL6A 和斑马鱼 Bcl6aa 蛋白在组成 BTB/POZ、PEST 和锌指结构域中高度保守。在早期斑马鱼胚胎发生过程中观察到 在侧中胚层表达,这是早期髓样细胞发育的部位,后来在大脑、眼睛和胸腺中表达。纯合 突变体正常发育至受精后约 14 天(dpf),之后其随后的生长和成熟受到严重影响,相对存活率降低,杂合 突变体表现出中间表型。免疫细胞发育分析显示,在纯合和杂合 突变体中,淋巴样细胞和巨噬细胞数量明显减少,在纯合突变体中更为严重。相比之下,中性粒细胞数量不受影响。只有纯合 突变体显示出对创伤的巨噬细胞迁移能力下降和控制细菌感染能力降低。总的来说,这表明 BCL6A 在进化过程中具有很强的保守性,包括在巨噬细胞生物学中的作用。